Search Results 1411-1420 of 22002 for Inhibition
Mayo Clinic Researchers: TNF Inhibitors May Increase Cancer Risk in the Eye. Robert Nellis. November 13, 2014. Cancer. Mayo Clinic Researchers Identify First ...
... inhibition of GH release. Participation eligibility. Participant eligibility includes age, gender, type and stage of disease, and previous treatments or ...
ACE inhibitors and ARBs. Drugs called angiotensin-converting enzyme (ACE) inhibitors or angiotensin II receptor blockers (ARBs) help open blood vessels and ...
... inhibitors. Participation eligibility. Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns ...
Contact us about research collaboration or about our studies on apoptosis, topoisomerase poisons, development of PARP inhibitors and novel anti-neoplastic ...
Treatment With Histone Deacetylase Inhibitor ... Pharmacologic Resuscitation: Cell Protective Mechanisms of Histone Deacetylase Inhibition in Lethal Hemorrhagic ...
Developing a new drug for women with resistance to aromatase inhibitors ... inhibitor therapy. Cancer Research. 2016; doi:10.1158/0008-5472.CAN-16-1371 ...
In contrast, Camostat, a trypsin inhibitor which is used in other countries for AP, has limited effects. In addition, 5-20 hours after AP induction ...
... inhibition by BM-CAFs. Our additional preliminary studies demonstrate that dual targeting of multiple myeloma cells and BM-CAFs by CAR-T cells is safe in ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Hurry to 3X your gift’s impact on cancer research and care!